NCT02203006

Brief Summary

The purpose of this study is to improve our knowledge concerning HIV infection, treated or not, in the current conditions of care to optimize it.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,613

participants targeted

Target at P75+ for not_applicable

Timeline
55mo left

Started Oct 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Oct 2011Nov 2030

Study Start

First participant enrolled

October 19, 2011

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

July 25, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 29, 2014

Completed
16.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 19, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 19, 2030

Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

19.1 years

First QC Date

July 25, 2014

Last Update Submit

April 30, 2026

Conditions

Patients Affected by the HIV

Keywords

HIV,infection,cohort

Outcome Measures

Primary Outcomes (1)

  • HIV infection

    The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)

    10 years

Secondary Outcomes (3)

  • Comorbidity and complication in HIV infected patients

    10 years

  • efficiency of the current antiretroviral therapeutic diets

    10 years

  • Blood sample collection

    10 years

Study Arms (1)

OVIHD

OTHER

Cohort and a blood sample collection will be done with data and blood of HIV infected patients

Biological: OVIHD

Interventions

OVIHDBIOLOGICAL

7 ml of blood will be taken during a follow-up consultation and kept in a biological collection. Clinical data will be collected in a database.

Also known as: Blood sample
OVIHD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged ≥18 years old,
  • Patients with an HIV infection
  • patients having given their written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Hôtel Dieu

Paris, 75004, France

Location

MeSH Terms

Conditions

Infections

Interventions

Blood Specimen Collection

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Jean-Marc Tréluyer, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 25, 2014

First Posted

July 29, 2014

Study Start

October 19, 2011

Primary Completion (Estimated)

November 19, 2030

Study Completion (Estimated)

November 19, 2030

Last Updated

May 6, 2026

Record last verified: 2026-04

Locations

FR(1)